Funding
Turn ideas into impact
Show Me
Due: January 7, 2027
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
US $375,000
Type
Grant
Source
Federal
Opp Number
PAR-24-214
Due: January 7, 2027
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
Type
Grant
Source
Federal
Opp Number
PAR-25-070
Due: January 7, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-026
Due: January 7, 2027
National Cancer Institute’s Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
US $499,999
Type
Grant
Source
Federal
Opp Number
PAR-25-081
Due: January 7, 2027
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-355
Due: January 7, 2027
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
US $1,515,000
Type
Grant
Source
Federal
Opp Number
PAR-25-025
Due: January 7, 2027
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Type
Grant
Source
Federal
Opp Number
PAR-25-167
Due: January 7, 2027
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-354
Due: January 7, 2027
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
Type
Grant
Source
Federal
Opp Number
PAR-25-159
Submit your funding opportunity.
Do you have a grant, incentive, funding competition, or other funding source to share?